Eosinophilic Asthma
📧 Sign up to get email alerts when something new happens for Eosinophilic Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma [Phase 3]
Open-label extension study assessing the long-term safety and efficacy of reslizumab (3.0 mg/kg) in eosinophilic asthma patients aged 12-75;…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: A Phase IIa Study of KHK4563 [Phase 2]
This update reports the completion of a Phase IIa study of KHK4563 in patients with uncontrolled and suspected eosinophilic asthma.